The United States Omeprazole market shows no significant increase in value over the previous month. The increase seen during November was negligible and did not lead to a change in trend in December. Towards the end of December, buyers became more cautious with what they were buying, maintaining stable prices as long as they had adequate supply from channels supplying from Asia. Sales of both prescriptive and over-the-counter omeprazole remained consistent throughout December, driven by medical necessity, and limited competition from generic brands. Since omeprazole is such a frequently prescribed medication, it makes sense for buyers to continue with established buying plans rather than making impulse purchase decisions. The supply side remained stable throughout December, and no major issues arose that would have altered the supply side. Looking forward, the supply attitude is starting to improve with the anticipation of stocking for January 2026; therefore, buyers are preparing to potentially increase prices early next year since they are concerned about a short-term supply squeeze during January 2026. However, any increase will likely be moderate.
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
